Antimicrobial Activity of Clove Extracts against Microorganisms Isolated from Vaginal Discharge

Infections of the genitourinary and reproductive tracts pose significant health concerns for women, particularly those of reproductive age. These infections often manifest as vaginal discharge and can be caused by a variety of microorganisms, including pathogenic bacteria and fungi. Traditional antibiotic treatments are increasingly challenged by the rise of antibiotic-resistant strains, underscoring the need for alternative therapies. This study aimed to isolate and identify microorganisms from vaginal swab samples and evaluate the antimicrobial efficacy of clove (Eugenia caryophyllata) extracts against these isolates. Using CLED agar, nutrient agar, and Sabouraud dextrose agar, a diverse range of bacterial and fungal flora were isolated from eight vaginal swab samples. The primary bacterial isolates included Proteus mirabilis, Escherichia coli, Staphylococcus aureus, and Lactobacillus spp., while Candida albicans was the main fungal isolate. Biochemical tests confirmed the identity of these microorganisms. The study found that ethanol clove extract exhibited significant antimicrobial activity, particularly against Staphylococcus aureus and Candida albicans, with the minimum inhibitory concentration (MIC) values being 20 mg/ml and 10 mg/ml, respectively. Additionally, ciprofloxacin, used as a control antibiotic, showed maximum inhibition against Lactobacillus spp., highlighting a potential risk for disrupting beneficial vaginal flora when using conventional antibiotics. The findings suggest that ethanol clove extract could serve as an effective alternative antimicrobial agent, reducing the risk of antibiotic resistance and preserving the balance of the vaginal microbiome. This research emphasizes the importance of exploring plant-based antimicrobial agents as viable alternatives to traditional antibiotics. The significant antimicrobial properties of clove extract against common vaginal pathogens offer promising implications for future therapeutic applications in managing vaginal infections.